Table 2.

Demographic characteristics, family history of autoimmune disease, lesion distribution, and treatment modalities distributed by lupus erythematosus (LE) subtype

	CCLE	SCLE	ACLE	LE-Nonspecific	Total Childhood Cutaneous LE	Neonatal LE
N	17	6	13	15	38	15
Sex
Female (%)	9 (52.9)	5 (83.3)	12 (92.3)	10 (66.7)	26 (68.4)	9 (60.0)
Male (%)	8 (47.1)	1 (16.7)	1 (7.7)	5 (33.3)	12 (31.6)	6 (40.0)
Female:male ratio	1.1:1	5:1	12:1	2:1	2.2:1	1.5:1
Race
Black (%)	6 (35.3)	3 (50.0)	5 (38.5)	8 (53.3)	17 (44.7)	6 (40.0)
Asian (%)	2 (11.8)	0	1 (7.7)	0	3 (7.9)	0
Caucasian (%)	5 (29.4)	3 (50.0)	6 (46.2)	6 (40.0)	13 (34.2)	8 (53.3)
Latino (%)	4 (23.5)	0	1 (7.7)	1 (6.7)	5 (13.2)	0
Unspecified (%)	0	0	0	0	0	1 (6.7)
Mean age at onset (Median, Range)	9.9 years (11, 2–15)	11.3 years (12, 2–16)	13.6 years (13, 10–18)	13.5 years (13, 9–18)	11.6 years (12.5, 2–17)	3.8 weeks (4, 0–8)
Family history
Immediate (%)	3 (17.6)	0	4 (30.8)	8 (53.3)	10 (26.3)	13 (86.7)
Distant (%)	1 (5.9)	3 (50.0)	5 (38.5)	3 (20.0)	7 (18.4)	0
None (%)	13 (76.5)	3 (50.0)	4 (30.8)	4 (26.7)	21 (55.3)	2 (13.3)
Distribution
Head (%)	15 (88.2)	6 (100)	11 (84.6)	8 (53.3)	35 (92.1)	15 (100)
Trunk (%)	3 (17.6)	4 (66.7)	4 (30.8)	7 (46.7)	12 (31.6)	6 (40.0)
Upper extremities (%)	7 (41.2)	5 (83.3)	4 (30.8)	10 (66.7)	20 (52.6)	3 (20.0)
Lower extremities (%)	3 (17.6)	4 (66.7)	3 (23.1)	7 (46.7)	10 (26.3)	4 (26.7)
Genitals (%)	0	0	0	1 (6.7)	1 (2.6)	1 (6.7)
Treatment
Topical (%)	15 (88.2)	4 (66.7)	9 (69.2)	7 (46.7)	26 (68.4)	11 (73.3)
Systemic (%)	12 (70.6)	6 (100)	13 (100)	15 (100)	33 (86.8)	0

LE, lupus erythematosus; CCLE, chronic cutaneous lupus erythematosus; SCLE, subacute cutaneous lupus erythematosus; ACLE, acute cutaneous lupus erythematosus